Boston Scientific trims 2026 sales and earnings guidance due to slowing growth in key product lines, including Watchman and electrophysiology, affecting its…
Abbott launches a comprehensive heart valve study assessing its TriClip device's real-world safety and performance in treating tricuspid valves.